Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhu, M.
Right arrow Articles by Shima, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhu, M.
Right arrow Articles by Shima, K.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 45, Issue 7 941-946, Copyright © 1996 by American Diabetes Association


ARTICLES

Poor capacity for proliferation of pancreatic beta-cells in Otsuka-Long-Evans-Tokushima Fatty rat: a model of spontaneous NIDDM

M Zhu, Y Noma, A Mizuno, T Sano and K Shima
Department of Laboratory Medicine, School of Medicine, University of Tokushima, Tokushima City, Japan.

Otsuka-Long-Evans-Tokushima Fatty (OLETF) rat, a genetic model of spontaneous development of NIDDM, exhibits hyperglycemic obesity with hyperinsulinemia and insulin resistance similar to that in humans. It is still unclear whether a defect in the beta-cell proliferation per se is the primary pathogenetic event in OLETF rat. To determine whether it is, we used partially pancreatectomized rats as a model, with administration of phlorizin to control blood glucose level, to examine whether the capacity for proliferation of beta-cells during hyperglycemia or normoglycemia differs between OLETF and their diabetes-resistant counterparts, Long-Evans-Tokushima-Otsuka (LETO) rats. We also examined whether such a defect, if present, could be improved by nicotinamide. Male rats, 6 weeks of age, were allocated at random to two groups: 70% pancreatectomy (Px) and sham-pancreatectomy (sham). Each group was divided into four subgroups by date of killing after surgery: 3-day, 7-day, 28-day (treated with phlorizin, nicotinamide, or saline), and 91-day. A sustained hyperglycemia was evident in the Px OLETF rats after surgery, which was associated with insufficient proliferation of beta-cells, characterized by decrease in beta-cell labeling index in proportion to decrease in beta-cell mass and reduction in insulin content in the remnant pancreas. This defect was unaffected by restoration of normoglycemia induced by phlorizin injection. Administration of nicotinamide, however, ameliorated the sustained hyperglycemia by increasing beta-cell proliferation. These findings suggest that OLETF rats have poor capacity for proliferation of pancreatic beta-cells and that this change may be the critical pathogenetic event before the onset of overt diabetes.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
K. Maedler, J. Oberholzer, P. Bucher, G. A. Spinas, and M. Y. Donath
Monounsaturated Fatty Acids Prevent the Deleterious Effects of Palmitate and High Glucose on Human Pancreatic {beta}-Cell Turnover and Function
Diabetes, March 1, 2003; 52(3): 726 - 733.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. E. Butler, J. Janson, S. Bonner-Weir, R. Ritzel, R. A. Rizza, and P. C. Butler
{beta}-Cell Deficit and Increased {beta}-Cell Apoptosis in Humans With Type 2 Diabetes
Diabetes, January 1, 2003; 52(1): 102 - 110.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Iwase, Y. Uchizono, K. Tashiro, D. Goto, and M. Iida
Islet Hyperperfusion During Prediabetic Phase in OLETF Rats, a Model of Type 2 Diabetes
Diabetes, August 1, 2002; 51(8): 2530 - 2535.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
K. Maedler, A. Fontana, F. Ris, P. Sergeev, C. Toso, J. Oberholzer, R. Lehmann, F. Bachmann, A. Tasinato, G. A. Spinas, et al.
FLIP switches Fas-mediated glucose signaling in human pancreatic beta cells from apoptosis to cell replication
PNAS, June 11, 2002; 99(12): 8236 - 8241.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. Li, M. Seno, H. Yamada, and I. Kojima
Promotion of {beta}-Cell Regeneration by Betacellulin in Ninety Percent-Pancreatectomized Rats
Endocrinology, December 1, 2001; 142(12): 5379 - 5385.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. Metz, S. Holland, L. Johnson, E. Espling, M. Rabaglia, V. Segu, J. S. Brockenbrough, and P. O. Tran
Inosine-5'-Monophosphate Dehydrogenase Is Required for Mitogenic Competence of Transformed Pancreatic {beta} Cells
Endocrinology, January 1, 2001; 142(1): 193 - 204.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. Hida, J. Wada, H. Zhang, K. Hiragushi, Y. Tsuchiyama, K. Shikata, and H. Makino
Identification of genes specifically expressed in the accumulated visceral adipose tissue of OLETF rats
J. Lipid Res., October 1, 2000; 41(10): 1615 - 1622.
[Abstract] [Full Text]


Home page
Am. J. Pathol.Home page
M. Koyama, R.-i. Wada, H. Sakuraba, H. Mizukami, and S. Yagihashi
Accelerated Loss of Islet ß Cells in Sucrose-Fed Goto-Kakizaki Rats, a Genetic Model of Non-Insulin-Dependent Diabetes Mellitus
Am. J. Pathol., August 1, 1998; 153(2): 537 - 545.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1996 by the American Diabetes Association.